AI assistant
MACROGENICS INC — Director's Dealing 2018
Mar 1, 2018
34129_dirs_2018-03-01_5d46b7c4-659e-4d19-a317-56fe5189c7bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-02-28
Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | M | 1000 | $0.94 | Acquired | 10100 | Direct |
| 2018-02-28 | Common Stock | S | 1000 | $25.005 | Disposed | 9100 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | Employee stock option (right to buy) | $0.94 | M | 1000 | Disposed | 2019-03-23 | Common Stock (1000.0) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017.
F2: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.01.The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.